Igor Rybkin

Igor Rybkin, MD PhD, is a Clinical Research Medical Director at Amgen since November 2021. Prior to this role, Rybkin served as the Vice Chair of the Molecular Tumor Board at the Henry Ford Cancer Institute from November 2017 to November 2021 and was a Clinical Assistant Professor at Wayne State University School of Medicine from March 2017 to November 2021. Rybkin also held the position of Senior Staff Physician at Henry Ford Health System from July 2012 to November 2021. Rybkin obtained a Doctor of Medicine (M.D.) from Orenburg State Medical Academy and a Doctor of Philosophy (Ph.D.) in Genes & Development from UT Southwestern Medical Center at Dallas, as well as education from the University of Michigan.